ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CFMS Conformis Inc

2.26
0.00 (0.00%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Conformis Inc NASDAQ:CFMS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.26 2.26 2.15 0 01:00:00

Conformis, Inc. to Participate in the 32nd Annual Piper Sandler Healthcare Conference

24/11/2020 9:30pm

GlobeNewswire Inc.


Conformis (NASDAQ:CFMS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Conformis Charts.

Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer, will participate in the 32nd Annual 2020 Piper Sandler Virtual Healthcare Conference taking place December 1-3, 2020. Conformis will provide an investor presentation and will be available for virtual one-on-one meetings during the conference.

About Conformis, Inc.

Conformis is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which we refer to as personalized, individualized, or sometimes as customized, to fit each patient’s unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers. In clinical studies, the Conformis iTotal CR knee replacement system demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.

For more information, visit www.conformis.com. To receive future releases in e-mail alerts, sign up at ir.conformis.com.

Contact

Investor Contact:
Investor Relations
ir@conformis.com
(781) 374-5598

1 Year Conformis Chart

1 Year Conformis Chart

1 Month Conformis Chart

1 Month Conformis Chart